Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
Clinical trial NCT05170334 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05170334
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2025-12-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.